| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |